Rexulti Works for Agitation in Alzheimer's, Despite Risks, Says FDA Staff
Por um escritor misterioso
Descrição
Increased mortality risk consistent with other antipsychotics in elderly dementia patients
Frontiers Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions
The Madness of Pop Psychiatry - by Nick Jikomes, PhD
Jefferies: Lundbeck and Otsuka have potential blockbuster candidate within reach — MedWatch
Brexpiprazole (Rexulti) Approved for Alzheimer's Agitation
Jefferies: Lundbeck and Otsuka have potential blockbuster candidate within reach — MedWatch
FDA Approves Rexulti for Agitation Associated With Dementia Due to Alzheimer's Disease
Otsuka/Lundbeck's Rexulti Appears Effective For Alzheimer's Dementia Agitation, US FDA Says :: Pink Sheet
FDA approves supplemental new drug application for Rexulti to treat Alzheimer's agitation
Alzheimer's Facts & Figures in TX
BioXcel: Treatment For Agitation In Alzheimer's: Multi-Billion Opportunity
FDA fast-tracks drug for dementia agitation that increases risk of death 4 times - Study Finds
Alzheimer's Disease Insight Report: Current Therapies, Drug Pipeline and Outlook
de
por adulto (o preço varia de acordo com o tamanho do grupo)